Insider Transactions in Q4 2020 at Steris PLC (STE)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 01
2020
|
David B Lewis Director |
SELL
Open market or private sale
|
Direct |
1,560
-18.92%
|
$301,080
$193.79 P/Share
|
|
Dec 01
2020
|
David B Lewis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,560
+15.91%
|
$48,360
$31.61 P/Share
|
|
Nov 30
2020
|
Jacqueline B Kosecoff Director |
SELL
Bona fide gift
|
Indirect |
17,930
-22.69%
|
-
|
|
Nov 09
2020
|
Julia Madsen Sr. VP and GM, Life Sciences |
SELL
Open market or private sale
|
Direct |
1,900
-15.76%
|
$364,800
$192.46 P/Share
|
|
Nov 09
2020
|
Julia Madsen Sr. VP and GM, Life Sciences |
BUY
Exercise of conversion of derivative security
|
Direct |
1,900
+13.49%
|
$93,100
$49.43 P/Share
|
|
Nov 09
2020
|
Walter M Rosebrough Jr President & CEO |
SELL
Open market or private sale
|
Direct |
10,000
-5.64%
|
$1,940,000
$194.09 P/Share
|
|
Nov 06
2020
|
Walter M Rosebrough Jr President & CEO |
SELL
Open market or private sale
|
Direct |
10,000
-4.85%
|
$1,810,000
$181.44 P/Share
|
|
Nov 05
2020
|
Karen L Burton VP & CAO |
SELL
Open market or private sale
|
Direct |
4,602
-24.35%
|
$823,758
$179.43 P/Share
|
|
Nov 05
2020
|
Karen L Burton VP & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,852
+20.97%
|
-
|
|
Nov 05
2020
|
Cary L Majors SVP and President, Healthcare |
SELL
Open market or private sale
|
Direct |
2,000
-11.68%
|
$360,000
$180.0 P/Share
|
|
Nov 05
2020
|
Walter M Rosebrough Jr President & CEO |
SELL
Bona fide gift
|
Direct |
4,897
-6.42%
|
-
|
|
Oct 09
2020
|
Michael J Tokich Sr. Vice Pres., CFO |
SELL
Open market or private sale
|
Direct |
27,920
-14.49%
|
$5,248,960
$188.14 P/Share
|
|
Oct 09
2020
|
Michael J Tokich Sr. Vice Pres., CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
27,920
+27.54%
|
$1,479,760
$53.52 P/Share
|
|
Oct 08
2020
|
Michael J Tokich Sr. Vice Pres., CFO |
SELL
Open market or private sale
|
Direct |
80
-0.18%
|
$14,960
$187.0 P/Share
|
|
Oct 08
2020
|
Michael J Tokich Sr. Vice Pres., CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
80
+0.18%
|
$4,240
$53.52 P/Share
|
|
Oct 06
2020
|
Daniel A Carestio President and CEO |
SELL
Open market or private sale
|
Direct |
13,500
-7.91%
|
$2,457,000
$182.59 P/Share
|
|
Oct 06
2020
|
Daniel A Carestio President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,500
+25.32%
|
$1,039,500
$77.07 P/Share
|
|
Oct 01
2020
|
Julia Madsen Sr. VP and GM, Life Sciences |
BUY
Grant, award, or other acquisition
|
Direct |
1,396
+23.12%
|
-
|
|
Oct 01
2020
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
SELL
Open market or private sale
|
Direct |
12,252
-29.78%
|
$2,180,856
$178.0 P/Share
|
|
Oct 01
2020
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
BUY
Exercise of conversion of derivative security
|
Direct |
12,252
+22.95%
|
$649,356
$53.52 P/Share
|